India's Dr Reddy's says FDA raises concerns about plant
November 27, 2014 at 06:05 AM EST
MUMBAI, Nov 27 (Reuters) - Indian drugmaker Dr Reddy's Laboratories Ltd has received a letter from the U.S. Food and Drug administration highlighting concerns about its manufacturing plant in the southern Indian state of Andhra Pradesh, the company said on Thursday.